Sqale ApS is a Danish APS based in København Ø, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2023, the company has 2 employees and reported revenue of 185,4 t kr. in its latest annual filing.
Selskabets formål er avanceret og accelereret fremstilling af biologiske lægemidler, herunder biolægemidler og bio-løsninger ved hjælp af AI, kvantecomputere og avanceret kemisk og biologisk knowhow samt hermed beslægtet virksomhed.
In its most recent annual report (2025), Sqale ApS reported a gross profit of 185,4 t kr.. The figures on this page draw on 2 annual filings covering 2024 to 2025. The bottom line showed a net loss of 2,1 mio. kr., and the EBITDA margin stood at -1,004.3%.
